Examining the Therapeutic Potential of CRISPR-Cas9 Gene Editing in Spondyloarthritis: Efficacy of TNF Inhibitor Adalimumab: Research Article. International Journal of Research in Medical and Clinical Science, [S. l.], v. 2, n. 02, p. 20–30, 2024. DOI: 10.70829/ijrmcs.v2.i2.0724002. Disponível em: https://www.journalserapublications.com/index.php/ijrmcs/article/view/7. Acesso em: 21 oct. 2026.